These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16386050)

  • 41. Thiol-disulfide-dependent interconversion of active and latent forms of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Dotan I; Shechter I
    Biochim Biophys Acta; 1982 Nov; 713(2):427-34. PubMed ID: 7150622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Corsini A; Bernini F; Quarato P; Donetti E; Bellosta S; Fumagalli R; Paoletti R; Soma VM
    Cardiology; 1996; 87(6):458-68. PubMed ID: 8904671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Action of lovastatin--an inhibitor of cholesterol biosynthesis on bacterial bioluminescence].
    Baranova NA; Krĕier VG; Egorov NS
    Antibiot Khimioter; 1995 Aug; 40(8):12-6. PubMed ID: 8713431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of probucol on blood cholesterol and basal and lovastatin-induced 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in mice.
    Gebhard RL; Prigge WF; Andreini JP; Freeman ML
    J Lab Clin Med; 1991 Apr; 117(4):299-304. PubMed ID: 2010669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypocholesterolemic agents V: Inhibition of beta-hydroxy-beta-methylglutaryl coenzyme A reductase by substituted 4-biphenylylalkyl carboxylic acids and methyl esters.
    Boots SG; Boots MR; Guyer KE; Marecki PE
    J Pharm Sci; 1976 Sep; 65(9):1374-80. PubMed ID: 966157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
    Matsuoka T; Miyakoshi S; Tanzawa K; Nakahara K; Hosobuchi M; Serizawa N
    Eur J Biochem; 1989 Oct; 184(3):707-13. PubMed ID: 2509201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of ML-236B (compactin) on biliary excretion of bile salts and lipids, and on bile flow, in the rat.
    Kempen HJ; De Lange J; Vos-Van Holstein MP; Van Wachem P; Havinga R; Vonk RJ
    Biochim Biophys Acta; 1984 Jul; 794(3):435-43. PubMed ID: 6743675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of substrate supply in the regulation of cholesterol biosynthesis in rat hepatocytes.
    Pullinger CR; Gibbons GF
    Biochem J; 1983 Mar; 210(3):625-32. PubMed ID: 6870798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3-hydroxy-3-methylglutaryl-coenzyme A reductase A comparison of the modulation in vitro by phosphorylation and dephosphorylation to modulation of enzyme activity by feeding cholesterol- or cholestryamine-supplemented diets.
    Mitropoulos KA; Knight BL; Reeves BE
    Biochem J; 1980 Feb; 185(2):435-41. PubMed ID: 6249255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypocholesterolemic agents IV: inhibition of beta-hydroxy-beta-methyglutaryl coenzyme A reductase by arylalkenyl and arylepoxy hydrogen succinates and glutarates.
    Boots MR; Marecki PE; Boots SG; Guyer KE
    J Pharm Sci; 1976 May; 65(5):724-7. PubMed ID: 932941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
    Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
    Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors.
    Krasovec M; Elsner P; Burg G
    Dermatology; 1993; 186(4):248-52. PubMed ID: 8513188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome p450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital.
    Watanabe I; Serizawa N
    Gene; 1998 Mar; 210(1):109-16. PubMed ID: 9524240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Panel discussion: Internal medicine creating future health care: 2. A lesson from the development of statin drugs].
    Endo A
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2200-6. PubMed ID: 27522778
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of diabetes on the expressed and total activities of 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver in vivo. Reversal by insulin treatment.
    Easom RA; Zammit VA
    Biochem J; 1985 Sep; 230(3):747-52. PubMed ID: 3904728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pannorin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor produced by Chrysosporium pannorum.
    Ogawa H; Hasumi K; Sakai K; Murakawa S; Endo A
    J Antibiot (Tokyo); 1991 Jul; 44(7):762-7. PubMed ID: 1880066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dihydrocompactin, a new potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase from Penicillium citrinum.
    Lam YK; Gullo VP; Goegelman RT; Jorn D; Huang L; DeRiso C; Monaghan RL; Putter I
    J Antibiot (Tokyo); 1981 May; 34(5):614-6. PubMed ID: 7275844
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals.
    Endo A; Tsujita Y; Kuroda M; Tanzawa K
    Biochim Biophys Acta; 1979 Nov; 575(2):266-76. PubMed ID: 508786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of prolonged administration of lovastatin, an inhibitor of cholesterol synthesis, on the morphology and function of rat Leydig cells.
    Andreis PG; Cavallini L; Mazzocchi G; Nussdorfer GG
    Exp Clin Endocrinol; 1990 Sep; 96(1):15-24. PubMed ID: 2279522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.